INVOLVEMENT OF THE MU-OPIATE RECEPTOR IN PERIPHERAL ANALGESIA
INVOLVEMENT OF THE MU-OPIATE RECEPTOR IN PERIPHERAL ANALGESIA
复制标题
DOI:
10.1016/0306-4522(89)90279-0
复制
发表时间:
1989-01-01
期刊:
影响因子:
3.3
通讯作者:
TAIWO, YO
中科院分区:
文献类型:
--
作者:
LEVINE, JD;TAIWO, YO
The intradermal injection of mu (morphine, Tyr-D-Ala-Gly-NMe-Phe-Gly-ol and morphiceptin), kappa (trans-3,4-dichloro-N-methyl-N[2-(1--pyroolidinyl)cyclohexyl]benzeneactemide) and delta [D-Pen2.5]-enkephalin and [D-Ser2]-[Leu]enkephalin-Thr) selective opioid-agonists, by themselves, did not significantly affect the mechanical nociceptive threshold in the hindpaw of the rat. Intradermal injection of mu, but not delta or kappa opioid-agonists, however, produced dose-dependent inhibition of prostaglandin E2-induced hyperalgesia. The analgesic effect of the mu-agonist morphine was dose-dependently antagonized by naloxone and prevented by co-injection of pertussis toxin. Morphine did not, however, alter the hyperalgesia induced by 8-bromo cyclic adenosine monophosphate. We conclude that the analgesic action of opioids on the peripheral terminals of primary afferents is via a binding site with characteristics of the mu-opioid receptor and that this action is mediated by inhibition of the cyclic adenosine monophosphate second messenger system.